172 related articles for article (PubMed ID: 23143411)
1. Effects of quetiapine extended release on sleep and quality of life in midlife women with major depressive disorder.
Frey BN; Haber E; Mendes GC; Steiner M; Soares CN
Arch Womens Ment Health; 2013 Feb; 16(1):83-5. PubMed ID: 23143411
[TBL] [Abstract][Full Text] [Related]
2. Effects of once-daily extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with major depressive disorder.
Locklear JC; Svedsäter H; Datto C; Endicott J
J Affect Disord; 2013 Jul; 149(1-3):189-95. PubMed ID: 23639212
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy.
Bauer M; McIntyre RS; Szamosi J; Eriksson H
Int J Neuropsychopharmacol; 2013 Sep; 16(8):1755-65. PubMed ID: 23672772
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies.
Trivedi MH; Bandelow B; Demyttenaere K; Papakostas GI; Szamosi J; Earley W; Eriksson H
Int J Neuropsychopharmacol; 2013 Sep; 16(8):1733-44. PubMed ID: 23673347
[TBL] [Abstract][Full Text] [Related]
5. Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarate.
Sheehan DV; Locklear J; Svedsäter H; Datto C
Int Clin Psychopharmacol; 2012 Sep; 27(5):239-48. PubMed ID: 22859063
[TBL] [Abstract][Full Text] [Related]
6. A pilot, 8-week, placebo lead-in trial of quetiapine extended release for depression in midlife women: impact on mood and menopause-related symptoms.
Soares CN; Frey BN; Haber E; Steiner M
J Clin Psychopharmacol; 2010 Oct; 30(5):612-5. PubMed ID: 20814317
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.
Katila H; Mezhebovsky I; Mulroy A; Berggren L; Eriksson H; Earley W; Datto C
Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study.
Bortnick B; El-Khalili N; Banov M; Adson D; Datto C; Raines S; Earley W; Eriksson H
J Affect Disord; 2011 Jan; 128(1-2):83-94. PubMed ID: 20691481
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine fumarate extended-release for the treatment of major depression with comorbid fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study.
McIntyre A; Paisley D; Kouassi E; Gendron A
Arthritis Rheumatol; 2014 Feb; 66(2):451-61. PubMed ID: 24504819
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
Liebowitz M; Lam RW; Lepola U; Datto C; Sweitzer D; Eriksson H
Depress Anxiety; 2010 Oct; 27(10):964-76. PubMed ID: 20734365
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels.
Montgomery SA; Altamura AC; Katila H; Datto C; Szamosi J; Eriksson H
Int Clin Psychopharmacol; 2014 Mar; 29(2):93-105. PubMed ID: 24162081
[TBL] [Abstract][Full Text] [Related]
12. Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression.
Kim SJ; Lee YJ; Lee YJ; Cho SJ
J Affect Disord; 2014 Mar; 157():33-40. PubMed ID: 24581825
[TBL] [Abstract][Full Text] [Related]
13. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.
Bauer M; Dell'osso L; Kasper S; Pitchot W; Dencker Vansvik E; Köhler J; Jørgensen L; Montgomery SA
J Affect Disord; 2013 Oct; 151(1):209-19. PubMed ID: 23810357
[TBL] [Abstract][Full Text] [Related]
14. A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder.
Bauer M; El-Khalili N; Datto C; Szamosi J; Eriksson H
J Affect Disord; 2010 Dec; 127(1-3):19-30. PubMed ID: 20884063
[TBL] [Abstract][Full Text] [Related]
15. Quetiapine XR: current status for the treatment of major depressive disorder.
Pae CU; Sohi MS; Seo HJ; Serretti A; Patkar AA; Steffens DC; Masand PS
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1165-73. PubMed ID: 20307622
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
Weisler RH; Montgomery SA; Earley WR; Szamosi J; Lazarus A
Int Clin Psychopharmacol; 2012 Jan; 27(1):27-39. PubMed ID: 22027845
[TBL] [Abstract][Full Text] [Related]
17. Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder.
Bauer M; Thase ME; Liu S; Earley W; Eriksson H
J Psychopharmacol; 2015 May; 29(5):565-74. PubMed ID: 25257148
[TBL] [Abstract][Full Text] [Related]
18. [The place of quetiapine extended release in the treatment of mental disorders].
Styczeń K; Datka W; Jaeschke R; Drozdowicz K; Siwek M; Dudek D
Psychiatr Pol; 2015; 49(1):67-80. PubMed ID: 25844411
[TBL] [Abstract][Full Text] [Related]
19. Extended release quetiapine fumarate in patients with major depressive disorder: suicidality data from acute and maintenance studies.
Weisler R; Montgomery SA; Earley WR; Szamosi J; Eriksson H
J Clin Psychiatry; 2014 May; 75(5):520-7. PubMed ID: 24816198
[TBL] [Abstract][Full Text] [Related]
20. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
Riesenberg RA; Baldytcheva I; Datto C
Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
